Companies: 10,795·Total market cap: $144.5T
Implanet S.A.

Implanet S.A.

IMPZYOTCHealthcare● Active
$0.08
+$0.00(+0.00%)
Market Cap$229257143
P/E Ratio
52W High$0.08
52W Low$0.08
Overview

Implanet S.A.(IMPZY)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · IMPZY · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.00impzy eps ttm · impzy earnings per shareEarnings history
PE Ratio (TTM)impzy pe ratio ttm · impzy price to earningsPE Ratio deep dive
Revenue (TTM)$21.8Mimpzy revenue ttm · impzy annual revenueFull revenue history
Dividend Yield0.22%does impzy pay dividends · impzy dividend yieldDividend history
Shares Outstanding2.91Bimpzy shares outstanding · impzy floatShares outstanding history
Next EarningsTBAimpzy earnings date · impzy next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$12.0M▲ +27.38% YoY
202320242025
implanet s.a. revenue · impzy revenue 2025
FY 2025Net Income-$4.2M▲ +3.59% YoY
202320242025
implanet s.a. net income · impzy profit 2025
FY 2025EPS$-0.00▲ +26.32% YoY
202320242025
impzy eps · implanet s.a. earnings per share 2025
TTM:Revenue: $21.8MNet Income: -$8.6MEPS: $-0.00View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y+100.00%

关于 Implanet S.A.

CEOLudovic Lastennet
IPO DateJan 23, 2017
Employees40
CountryFR

Implanet S.A. along with its affiliated entities, focuses on the creation, production, and distribution of medical implants for both spinal and orthopedic applications. The firm's product range encom…

what is implanet s.a. · impzy stock overview · implanet s.a. company profile · who is implanet s.a. ceo · impzy OTC · implanet s.a. headquarters · implanet s.a. business segments

关于股票概览与关键数据

Implanet S.A.(IMPZY)是 Medical - Devices 行业的 Healthcare 类公司,于 Jan 23, 2017 在 OTC 上市。截至最近交易日,IMPZY 股价为 $0.08,市值约为 $229.3M。过去12个月累计回报 +0.00%,年初至今回报 +0.00%。

2025 财年 Implanet S.A. 营收 $12.0M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Implanet S.A.(IMPZY)股价为 $0.08,在 OTC 上市,52周区间为 $0.08 – $0.08。

IMPZY 最新股价IMPZY quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议